Treatment of moderate to severe restless legs syndrome: 2-year safety and efficacy of rotigotine transdermal patch

BACKGROUND: Rotigotine is a unique dopamine agonist with activity across D1 through D5 receptors as well as select adrenergic and serotonergic sites. This study reports the 2-year follow-up safety and efficacy data of an ongoing open-label multicenter extension study (NCT00498186) of transdermal rot...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Högl, Birgit, Oertel, Wolfgang H, Stiasny-Kolster, Karin, Geisler, Peter, Beneš, Heike, García-Borreguero, Diego, Trenkwalder, Claudia, Poewe, Werner, Schollmayer, Erwin, Kohnen, Ralf
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2010
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2958158/
https://ncbi.nlm.nih.gov/pubmed/20920156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2377-10-86
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky